Showing results (1011-1020 of 1,065) with videos related to

Sort By:
Pageof 107
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 25, 2024
Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCUF Mesonero, Y Zabana, A Fernández-Clotet, et al.
European Journal of Human Genetics : EJHG|September 16, 2004
An excess of chromosome 1 breakpoints in male infertilityIben Bache, Elvire Van Assche, Sultan Cingoz, et al.
Nature Genetics|April 10, 2025
Mutations in the small nuclear RNA gene RNU2-2 cause a severe neurodevelopmental disorder with prominent epilepsyDaniel Greene, Koenraad De Wispelaere, Jon Lees, et al.
Journal of Crohn'S & Colitis|July 31, 2023
Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA RegistryMaría José García, Montserrat Rivero, Agnès Fernández-Clotet, et al.
Emerging Infectious Diseases|November 18, 2021
Multistate Outbreak of SARS-CoV-2 Infections, Including Vaccine Breakthrough Infections, Associated with Large Public Gatherings, United StatesRadhika Gharpure, Samira Sami, Johanna Vostok, et al.
Therapeutic Advances in Gastroenterology|February 24, 2026
Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCUFrancisco Mesonero, Yamile Zabana, Agnès Fernández-Clotet, et al.
Journal of Crohn'S & Colitis|February 1, 2022
Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCUManuel Barreiro-de Acosta, Sabino Riestra, Margalida Calafat, et al.
Revista Espanola De Salud Publica|February 23, 2021
[Beginnings, evolution and current situation of the Newborn Screening Programs in Spain.]José Luis Marín Soria, José Manuel González de Aledo Castillo, Ana Argudo Ramírez, et al.
Alimentary Pharmacology & Therapeutics|July 5, 2025
Effectiveness and Safety of First-Line Non-Bismuth Quadruple Concomitant Therapy Versus Single-Capsule Bismuth Quadruple TherapyOlga P Nyssen, Nuria Montes, Ángeles Pérez-Aísa, et al.
Pageof 107